Brief: Hookipa Pharma Announces Q3 2022 Financial Results
14/11/2022 12:49
Nov 14 (Reuters) - Hookipa Pharma Inc HOOK.O :
* HOOKIPA PHARMA ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES A BUSINESS UPDATE
* REVENUE WAS $2.2 MILLION FOR THREE MONTHS ENDED SEPTEMBER
30,
2022, COMPARED TO $3.9 MILLION FOR THREE MONTHS ENDED SEPTEMBER
30, 2021
* QTRLY NET LOSS PER $0.25
* Q3 EARNINGS PER SHARE VIEW $-0.28, REVENUE VIEW $2.9
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbrGzr9
Further company coverage: HOOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)